These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18576329)

  • 1. Cell surface expression of TNFRI in tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Nedjai et al.
    Todd I; Tighe P; Rebelo S; Powell R
    Arthritis Rheum; 2008 Jul; 58(7):2213-4; author reply 2214-5. PubMed ID: 18576329
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation.
    Yousaf N; Gould DJ; Aganna E; Hammond L; Mirakian RM; Turner MD; Hitman GA; McDermott MF; Chernajovsky Y
    Arthritis Rheum; 2005 Sep; 52(9):2906-16. PubMed ID: 16142754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
    Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression.
    Siebert S; Fielding CA; Williams BD; Brennan P
    FEBS Lett; 2005 Sep; 579(23):5193-8. PubMed ID: 16162344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Siebert et al.
    Todd I; Nowlan ML; Drewe E; Tighe PJ; Powell RJ
    Arthritis Rheum; 2005 Sep; 52(9):2952; author reply 2952-3. PubMed ID: 16142725
    [No Abstract]   [Full Text] [Related]  

  • 8. A boy with fever and whorl keratopathy.
    Halligan C; Heese BA; Mellor G; Michels VV; Reed A
    J Rheumatol; 2006 Jun; 33(6):1210-1. PubMed ID: 16755678
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Yousaf N; Chernajovsky Y; Stjernberg-Salmela S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD
    Arthritis Rheum; 2008 Jan; 58(1):273-83. PubMed ID: 18163488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
    Jacobelli S; André M; Alexandra JF; Dodé C; Papo T
    Rheumatology (Oxford); 2007 Jul; 46(7):1211-2. PubMed ID: 16935919
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
    Nakamura M; Tokura Y
    Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
    Siebert S; Amos N; Lawson TM
    Rheumatology (Oxford); 2008 Feb; 47(2):228-9. PubMed ID: 18056150
    [No Abstract]   [Full Text] [Related]  

  • 14. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
    Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
    Nakamura M; Kobayashi M; Tokura Y
    Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) or familial Hibernian fever: presentation in a four-day-old infant.
    Savage T; Loftus BG; Tormey V; McDermott MF; Moylett E
    J Clin Rheumatol; 2008 Dec; 14(6):342-5. PubMed ID: 18690165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome.
    Turner MD; Chernajovsky Y
    Rheumatology (Oxford); 2011 Aug; 50(8):1525-6; author reply 1526-9. PubMed ID: 21672967
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble tumor necrosis factor receptor levels in familial Mediterranean fever.
    Dror Y; Hahn T; Barash Y
    J Rheumatol; 1998 Dec; 25(12):2481-2. PubMed ID: 9858459
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.